Captor Therapeutics is a publicly-listed (WSE:CTX) innovative drug discovery and development company focused on targeting the undruggable proteome using targeted protein degradation. Our mission is to transform lives of patients suffering from cancer, autoimmunity and neurodegenerative diseases. Our groundbreaking technology is perfectly suited to create new drug candidates with the potential to ease patients' burden and cure conditions that so far have only been poorly treatable.
View Top Employees from Captor Therapeutics SAWebsite | http://captortherapeutics.com/ |
Revenue | $5 million |
Employees | 89 (71 on RocketReach) |
Founded | 2017 |
Address | 11 Ul. Duska, Wroclaw, Lower Silesian Voivodeship 54 427, PL |
Phone | +48 537 869 089 |
Technologies |
JavaScript,
HTML,
Nginx
+6 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Captor Therapeutics SA employee's phone or email?
The Captor Therapeutics SA annual revenue was $5 million in 2024.
Katarzyna Kaczanowska is the Head of Medicinal Chemistry of Captor Therapeutics SA.
71 people are employed at Captor Therapeutics SA.
Captor Therapeutics SA is based in Wroclaw, Lower Silesian Voivodeship.
The NAICS codes for Captor Therapeutics SA are [325, 32, 32541, 3254].
The SIC codes for Captor Therapeutics SA are [28, 283].